X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1463) 1463
Book Review (424) 424
Publication (148) 148
Book Chapter (30) 30
Conference Proceeding (13) 13
Government Document (12) 12
Dissertation (7) 7
Book / eBook (3) 3
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (994) 994
humans (785) 785
anti-angiogenic therapy (708) 708
oncology (563) 563
angiogenesis (521) 521
animals (491) 491
cancer (483) 483
endothelial growth-factor (360) 360
bevacizumab (285) 285
angiogenesis inhibitors - therapeutic use (279) 279
female (277) 277
vascular endothelial growth factor (256) 256
mice (249) 249
male (229) 229
anti-angiogenic (225) 225
tumors (223) 223
chemotherapy (218) 218
angiogenesis inhibitors - pharmacology (205) 205
neovascularization, pathologic - drug therapy (194) 194
pharmacology & pharmacy (189) 189
metastasis (178) 178
vegf (169) 169
neoplasms - drug therapy (158) 158
tumor angiogenesis (158) 158
antiangiogenic therapy (154) 154
care and treatment (148) 148
antineoplastic agents (147) 147
antimitotic agents (143) 143
cell line, tumor (143) 143
analysis (137) 137
therapy (130) 130
middle aged (127) 127
in-vivo (120) 120
expression (116) 116
health aspects (114) 114
growth (113) 113
treatment outcome (113) 113
research (112) 112
antineoplastic agents - therapeutic use (110) 110
neoplasms - blood supply (110) 110
aged (106) 106
adult (101) 101
cells (101) 101
medicine & public health (100) 100
angiogenesis inhibitors (96) 96
cell biology (96) 96
anti-angiogenic agents (94) 94
article (93) 93
biochemistry & molecular biology (93) 93
renal-cell carcinoma (92) 92
vascular endothelial growth factor a - antagonists & inhibitors (92) 92
vascular endothelial growth factor a - metabolism (92) 92
breast-cancer (91) 91
neovascularization (90) 90
antineoplastic agents - pharmacology (89) 89
tumor-growth (89) 89
cancer therapies (88) 88
inhibition (88) 88
phase-ii trial (85) 85
cell proliferation - drug effects (83) 83
glioblastoma (83) 83
hypoxia (83) 83
neovascularization, pathologic - pathology (82) 82
review (81) 81
apoptosis (79) 79
medicine, research & experimental (78) 78
angiogenesis inhibitors - administration & dosage (76) 76
endothelium (76) 76
xenograft model antitumor assays (76) 76
drug therapy (75) 75
antineoplastic combined chemotherapy protocols - therapeutic use (74) 74
in-vitro (74) 74
metastatic colorectal-cancer (72) 72
neoplasms - pathology (72) 72
tyrosine kinase inhibitor (71) 71
rats (70) 70
chemistry, medicinal (68) 68
survival (68) 68
immunotherapy (67) 67
brain neoplasms - drug therapy (66) 66
endothelial cells (66) 66
sunitinib (66) 66
mice, nude (65) 65
anti-angiogenic activity (63) 63
cancer research (63) 63
colorectal cancer (62) 62
endothelial-cells (62) 62
hematology, oncology and palliative medicine (62) 62
solid tumors (62) 62
neovascularization, pathologic - metabolism (61) 61
dose-response relationship, drug (60) 60
neovascularization, pathologic (60) 60
phase-iii trial (60) 60
immunohistochemistry (59) 59
prognosis (58) 58
proteins (58) 58
anti-angiogenic treatment (57) 57
mice, inbred balb c (57) 57
anti-angiogenic agent (56) 56
breast cancer (56) 56
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1428) 1428
French (55) 55
German (13) 13
Spanish (5) 5
Japanese (4) 4
Korean (3) 3
Polish (2) 2
Portuguese (2) 2
Chinese (1) 1
Czech (1) 1
Italian (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Pediatric Blood & Cancer, ISSN 1545-5009, 09/2014, Volume 61, Issue 9, pp. 1603 - 1609
Journal Article
Drug Development Research, ISSN 0272-4391, 09/2008, Volume 69, Issue 6, pp. 329 - 339
Anti‐angiogenesis is a promising strategy for the treatment of cancer. Integrins, consisting of two noncovalently bound transmembrane α and β subunits, are an... 
integrin α | anti‐angiogenic therapy | metastasis | angiogenesis | Angiogenesis | Anti-angiogenic therapy | Metastasis | Integrin α | anti-angiogenic therapy | integrin αvβ3
Journal Article
The Journal of Pathology, ISSN 0022-3417, 02/2017, Volume 241, Issue 3, pp. 362 - 374
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 05/2012, Volume 122, Issue 5, pp. 1832 - 1848
Cancer development, progression, and metastasis are highly dependent on angiogenesis. The use of antiangiogenic drugs has been proposed as a novel strategy to... 
MEDICINE, RESEARCH & EXPERIMENTAL | VASCULAR NORMALIZATION | INDUCIBLE FACTOR-1-ALPHA | SQUAMOUS CARCINOGENESIS | PANCREATIC NEUROENDOCRINE TUMORS | MOUSE MODEL | ANTI-ANGIOGENIC THERAPY | GROWTH-FACTOR | K14-HPV16 TRANSGENIC MICE | NF-KAPPA-B | MALIGNANT PROGRESSION | Proto-Oncogene Proteins c-met - metabolism | Genetic Therapy | Pancreatic Neoplasms - metabolism | Uterine Cervical Neoplasms - blood supply | Pancreatic Neoplasms - blood supply | Drug Resistance, Neoplasm | NF-kappa B - metabolism | Uterine Cervical Neoplasms - pathology | Recombinant Proteins - biosynthesis | Semaphorin-3A - biosynthesis | Hypoxia-Inducible Factor 1, alpha Subunit - metabolism | Pericytes - pathology | Epithelial-Mesenchymal Transition | Angiogenesis Inhibitors - therapeutic use | Female | Indoles - pharmacology | Liver Neoplasms - secondary | Pyrroles - therapeutic use | Uterine Cervical Neoplasms - therapy | Semaphorin-3A - genetics | Neuroendocrine Tumors - pathology | Cell Hypoxia - drug effects | Neoplasm Invasiveness | Neuroendocrine Tumors - metabolism | Pancreatic Neoplasms - pathology | Angiogenesis Inhibitors - pharmacology | Mice, Transgenic | Combined Modality Therapy | Lymphatic Metastasis | Recombinant Proteins - genetics | Tumor Burden | Pyrroles - pharmacology | Animals | Uterine Cervical Neoplasms - virology | Indoles - therapeutic use | Mice | Neuroendocrine Tumors - therapy | Neovascularization, Physiologic | Neuroendocrine Tumors - blood supply | Pancreatic Neoplasms - therapy | Research | Angiogenesis inhibitors | Semaphorins | Cancer cells | Index Medicus | Abridged Index Medicus
Journal Article
Magnetic Resonance in Medicine, ISSN 0740-3194, 10/2017, Volume 78, Issue 4, pp. 1513 - 1522
PurposeTo compare the effects of two anti-angiogenic drugs, bevacizumab and a cytosolic phospholipase A2- inhibitor (AVX235), on the relationship between... 
micro‐CT | anti‐angiogenic therapy | permeability surface‐area product | tumor vasculature | DCE‐MRI | anti-angiogenic therapy | DCE-MRI | micro-CT | permeability surface-area product | ANTIVASCULAR THERAPIES | MICROVESSEL DENSITY | CYTOSOLIC PHOSPHOLIPASE-A2 | ANTIANGIOGENIC THERAPY | IN-VIVO | PROSTATE-CANCER | CLINICAL-TRIALS | BREAST-CANCER XENOGRAFTS | EX-VIVO | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Bevacizumab - pharmacology | Humans | Angiogenesis Inhibitors - pharmacology | X-Ray Microtomography - methods | Neovascularization, Pathologic - diagnostic imaging | Neoplasms, Experimental - diagnostic imaging | Xenograft Model Antitumor Assays | Animals | Neovascularization, Pathologic - drug therapy | Cell Line, Tumor | Magnetic Resonance Angiography - methods | Mice | Neoplasms, Experimental - drug therapy | Neoplasms, Experimental - blood supply | Antimitotic agents | CT imaging | Angiography | Magnetic resonance imaging | Analysis | Permeability | Antineoplastic agents | Cancer | Drugs | Medical imaging | Phospholipase A2 | Correlation coefficients | Breast cancer | Bevacizumab | Phospholipase | Angiogenesis | Blood volume | Computed tomography | Computation | Correlation analysis | Antiangiogenics | Xenografts | Tomography | Breast | Surface area | Tumors | Structure-function relationships | Index Medicus
Journal Article
Neoplasia, ISSN 1476-5586, 10/2018, Volume 20, Issue 10, pp. 1070 - 1082
Journal Article
Cancer journal (Sudbury, Mass.), ISSN 1528-9117, 03/2019, Volume 25, Issue 2, pp. 106 - 115
Journal Article
Biomaterials, ISSN 0142-9612, 2014, Volume 35, Issue 25, pp. 7214 - 7227
Abstract We described here the mechanisms by which small interfering RNA (siRNA) molecules incorporated in reconstituted high density lipoprotein (rHDL) were... 
Advanced Basic Science | Dentistry | Direct cytosolic delivery | Anti-angiogenic therapy | Cholesterol-conjugated siRNA | Tumor-selective accumulation | Reconstituted high density lipoprotein | Vascular endothelial growth factor | POLYELECTROLYTE COMPLEX MICELLES | RNA INTERFERENCE | CELLS | MATERIALS SCIENCE, BIOMATERIALS | ENGINEERING, BIOMEDICAL | SELECTIVE UPTAKE | CANCER-THERAPY | BREAST-CANCER | NANOPARTICLES | SCAVENGER RECEPTOR | ANTICANCER DRUGS | APOLIPOPROTEIN-A-I | Nanoparticles - chemistry | Humans | Cytosol - drug effects | Male | Vascular Endothelial Growth Factor A - metabolism | RNA, Messenger - metabolism | Vascular Endothelial Growth Factor A - genetics | Cholesterol - chemistry | RNA, Small Interfering - chemistry | MCF-7 Cells | RNA Interference | Female | Apolipoprotein A-I - chemistry | Guinea Pigs | Down-Regulation | RNA, Messenger - genetics | RNA, Small Interfering - pharmacology | Angiogenesis Inhibitors - pharmacology | Hep G2 Cells | Xenograft Model Antitumor Assays | Animals | Mice, Nude | Neovascularization, Pathologic - drug therapy | Cholesterol - pharmacology | Cytosol - metabolism | Mice | Drug Delivery Systems - methods | Angiogenesis Inhibitors - chemistry | Fluorescence | RNA | Tumors | Index Medicus | Strontium | Nanoparticles | Therapy | Lipoproteins | Ribonucleic acids | High density | Breast
Journal Article